Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Oophorectomy Stories

2007-01-05 06:16:04

By Schmidt, John W; Wollner, Debra; Curcio, Jessica; Riedlinger, June; Kim, Linda S Abstract Oral administration of conjugated equine estrogens (CEE) with and without the synthetic progestin medroxyprogesterone acetate (MPA) in postmenopausal women is associated with side-effects that include increased risk of stroke and breast cancer. The current evidence that transdermal administration of estradiol may provide a safer alternative to orally administered CEE is reviewed. Transdermally...

2006-07-24 15:04:29

CHICAGO (Reuters) - Women seeking relief from menopausal symptoms and diminished sex drive by taking testosterone as well as estrogen face a higher risk of breast cancer than with estrogen alone, a study said on Monday. Hormone replacement therapy often helps relieve debilitating symptoms of menopause such as hot flashes, night sweats and vaginal dryness. But since 2002, when a large study found an association with higher risks of breast cancer, strokes and blood clots, many women...

2006-07-13 07:25:00

By Martha Kerr NEW YORK -- There is an 80 percent reduction in the risk of ovarian, fallopian tube, and peritoneal cancers among women with the BRCA1 or BRCA2 gene mutation who undergo surgery to remove both ovaries, a procedure called bilateral salpingo-oophorectomy, Canadian researchers report in the Journal of the American Medical Association. Women with a BRCA1 or BRCA2 mutation, both of which are known to increase the risk of breast and ovarian cancers, are often advised to consider...

2006-07-11 22:25:59

NEW YORK (Reuters Health) - Women who gain weight after menopause increase their risk of developing invasive breast cancer. Conversely, weight loss reduces the risk, researchers report. The findings come from an analysis of data from the Nurses Health Study, published in the July 12 issue of the Journal of the American Medical Association. Dr. A. Heather Eliassen, from Brigham and Women's Hospital in Boston, and her team point out that many studies have established the relationship...

2006-06-08 14:04:24

NEW YORK (Reuters Health) - Women who carry mutations in the BRCA-1 or BRCA-2 genes have a high risk of developing breast cancer, and of having a recurrence. For such women with early breast cancer who desire breast-conserving surgery rather than a full mastectomy, extra treatments can help. Specifically, ovary removal or taking tamoxifen reduces the risk of cancer recurring in the same breast, down to levels no higher than among sporadic cases of breast cancer, study results...

2006-05-23 14:43:11

NEW YORK (Reuters Health) - Women who undergo surgical removal of both ovaries, a procedure called bilateral oophorectomy -- and who do not received hormone replacement therapy - have a significantly increased risk of experiencing moderate to severe hot flashes compared with women who have natural menopause, according to new report published in the journal Fertility and Sterility. Dr. Jodi A. Flaws, of the University of Maryland, Baltimore, and colleagues examined the association...

2006-04-11 15:10:16

By Andrew Stern CHICAGO (Reuters) - Estrogen-only hormone replacement therapy used to treat symptoms of menopause does not raise the risk of breast cancer for women who have had a hysterectomy, a study said on Tuesday. The finding contrasts with the higher risk of breast cancer among menopausal women taking estrogen plus progestin -- a combination designed to protect against uterine cancer. In a hysterectomy all or part of the uterus is removed. Hormone replacement therapy came...

2006-01-18 17:44:47

NEW YORK (Reuters Health) - Women with a genetic mutation that gives rise to colorectal cancer -- a condition called the Lynch syndrome -- are also at high risk for endometrial and ovarian cancer. Investigators now report that preventive hysterectomy and removal of the ovaries is effective in preventing these gynecologic cancers in such cases. Dr. Karen H. Lu, from University of Texas M. D. Anderson Cancer Center in Houston, and her associates report the findings in the New England...

2005-11-10 15:36:36

WASHINGTON (Reuters) - U.S. regulators said on Thursday they had issued warnings to dozens of companies that are promoting unproven "alternative" hormone therapies for women. The government sent letters to about 50 firms and Web sites that market supplements and creams as alternatives to hormone replacement therapy, warning them against making baseless claims that the treatments can help with serious diseases such as cancer, heart disease and osteoporosis. "It's particularly...

2005-10-07 18:21:45

NEW YORK (Reuters Health) - As many as one quarter of young women with uterine cancer also have ovarian cancer, new research suggests. Several groups advocate ovary-sparing treatment to safeguard fertility in young women with uterine cancer, the authors explain, but reports have suggested that these women have ovarian cancer rates ranging from 5 to 29 percent, according to a report in the journal Obstetrics & Gynecology. Dr. Ilana Cass from UCLA and Cedars-Sinai Medical Center,...